- Previous Close
4.4900 - Open
5.0300 - Bid 4.5200 x --
- Ask 4.5300 x --
- Day's Range
4.2600 - 4.5500 - 52 Week Range
4.1100 - 6.0000 - Volume
11,947,185 - Avg. Volume
10,502,388 - Market Cap (intraday)
4.552B - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 31, 2023
- 1y Target Est
--
Blue Sail Medical Co.,Ltd. engages in the health protection, medical device, and nursing businesses in China and internationally. It offers health protection gloves comprising disposable medical, latex, nitrile, PVC, and TPE/CPE gloves for applications in medical inspection and protection, industrial labor insurance, catering services, housework, and other areas. The company is also involved in the research, development, production, and sales of cardiac stents, coronary implantation and intervention, structural heart disease, and medical device products related to cardiac surgery. In addition, it provides first aid kits, medical first aid bags, family disaster prevention emergency kits and other first aid kits, epidemic prevention kits, reflective vests, masks, medical dressing products, etc. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is headquartered in Zibo, China.
www.bluesail.cn8,094
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 002382.SZ
View MorePerformance Overview: 002382.SZ
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002382.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002382.SZ
View MoreValuation Measures
Market Cap
4.55B
Enterprise Value
6.00B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.76
Price/Book (mrq)
0.52
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.21%
Return on Assets (ttm)
-1.29%
Return on Equity (ttm)
-4.42%
Revenue (ttm)
6B
Net Income Avi to Common (ttm)
-432.55M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
2.48B
Total Debt/Equity (mrq)
39.46%
Levered Free Cash Flow (ttm)
-1.46B